PIRAMAL PHARMA LIMITED

Scale -

Revenue is 8869 Rs Cr; in Top Quartile
Ebitda is 1135 Rs Cr; in Top Quartile; Annual Decline is -28 %
Quarterly Revenue is 2270 Rs Cr; in Top Quartile
Quarterly Ebitda is 195 Rs Cr; in Top Quartile

PBT is -27.02 Rs Cr; Annual Decline is -168 %; in Bottom Quartile
PAT is -383 Rs Cr; Annual Decline is -2205 %; in Bottom Quartile
Quarterly Profit is -88.95 Rs Cr; in Bottom Quartile

Profitability -

PBDIT Margin is 12.79 %; Annual Decline is -26 %; 5 Year CAGR is -9 %
PAT Margin is -4.31 %; Annual Decline is -2368 %; in Bottom Quartile
Quarterly Profit margin is -4 %; in Bottom Quartile

Return -

ROCE is 2.29 %; Annual Decline is -64 %; 5 Year CAGR is -23 %
ROA is -1.81 %; Annual Decline is -412 %; in Bottom Quartile
ROE is -3.99 %; Annual Decline is -456 %; in Bottom Quartile
Asset Turnover is 53 %; in Bottom Quartile

Efficiency -

Operating cash flow is 1653 Rs Cr; Annual Growth is 85 %; in Top Quartile; 5 Year CAGR is 21 %
Inventory Turnover Ratio is 3.3; 5 Year CAGR is 30 %

Quick Ratio is 0.87; in Bottom Quartile

Solvancy -

Long term Debt is 4300 Rs Cr; Annual Growth is 34 %; Continuous Growth over 3 years; in Top Quartile
Total Debt is 5495 Rs Cr; Continuous Growth over 3 years; in Top Quartile
Debt/Equity is 0.67; in Top Quartile
Contingent Liabilities is 882 Rs Cr; in Top Quartile; 5 Year CAGR is 25 %

Quality -

Operating cashflow/ebitda is 146 %; Annual Growth is 158 %; in Top Quartile; 5 Year CAGR is 24 %
Current Tax/PAT is -42 %; Annual Decline is -102 %; in Bottom Quartile

Operating cashflow/PAT is -431 %; Annual Decline is -109 %; in Bottom Quartile
Exceptional Items/PBT is 84 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: